GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matinas BioPharma Holdings Inc (STU:6LJ) » Definitions » 3-Year Revenue Growth Rate

Matinas BioPharma Holdings (STU:6LJ) 3-Year Revenue Growth Rate : 71.00% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Matinas BioPharma Holdings 3-Year Revenue Growth Rate?

Matinas BioPharma Holdings's Revenue per Share for the three months ended in Mar. 2024 was €0.00.

During the past 12 months, Matinas BioPharma Holdings's average Revenue per Share Growth Rate was -100.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 71.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Matinas BioPharma Holdings was 146.60% per year. The lowest was -37.00% per year. And the median was 25.20% per year.


Competitive Comparison of Matinas BioPharma Holdings's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Matinas BioPharma Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Matinas BioPharma Holdings's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matinas BioPharma Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Matinas BioPharma Holdings's 3-Year Revenue Growth Rate falls into.



Matinas BioPharma Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Matinas BioPharma Holdings  (STU:6LJ) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Matinas BioPharma Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Matinas BioPharma Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Matinas BioPharma Holdings (STU:6LJ) Business Description

Traded in Other Exchanges
Address
1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Matinas BioPharma Holdings (STU:6LJ) Headlines

No Headlines